Pharmaceuticals in Marine and Coastal Environments: Occurrence, Effects and Challenges in a Changing World

Pharmaceuticals in Marine and Coastal Environments: Occurrence, Effects and Challenges in a Changing World is divided into three sections that address a) coastal areas as the main entrance of pharmaceuticals into the ocean, b) the occurrence and distribution of pharmaceuticals in the environmental compartments of the ocean media, and c) the effects that such pollutants may cause to the exposed marine organisms. With its comprehensive discussions, the book provides a wide depiction of the current state-of-the-art on these topics in an effort to open new sources of investigation and find suitable solutions. Includes maps edited by the Water Information Network System of the International Hydrological Program (IHP-WINS)Provides a compilation of information regarding the occurrence and distribution of pharmaceuticals in the marine environment which will help establish new and more efficient monitoring programs and new research linesDepicts the most important results of environmental risk assessments that can be used as a first-step for further toxicological studies INDICE: Introduction: The sea as a route of global dissemination of pharmaceutical compounds Part I: Coastal environments - the gate of pharmaceuticals to marine environments 1. Point and diffuse sources of human pharmaceuticals in coastal zones 2. Aquaculture and animal husbandry as sources of pharmaceuticals in coastal settlements 3. Occurrence and accumulation of pharmaceuticals in urban estuaries 4. The impact of tides on the concentration of pharmaceuticals in estuarine zones 5. Seasonality of the occurrence of pharmaceuticals in coastal areas 6. Occurrence and distribution of pharmaceuticals in arid and semiarid coastal zones 7. Antibiotic resistance determinants in coastal environments 8. Occurrence and distribution of antibiotics and antibiotic resistances in estuarine and coastal sediments 9. Environmental fate of pharmaceuticals in the freshwater-seawater interface 10. Environmental risk assessment of pharmaceuticals in estuarine and coastal waters Part II: Occurrence and risk assessment of pharmaceutical compounds in marine environments 11. Sources and occurrence of pharmaceuticals in offshore seawater 12. New sampling methods for detecting pharmaceutical residues in seawater and sediments 13. Present and future challenges in the multiresidue determination of pharmaceuticals in marine samples 14. The impact of the hydrodynamics on the occurrence and bioavailability of pharmaceuticals in marine environment 15. Occurrence, sources and fate of pharmaceuticals in the arctic ocean 16. Pharmaceutical residues in the pristine antarctic ecosystem 17. On the search of a suitable indicator of pharmaceutical pollution in marine environments 18. Occurrence and bioavailability of pharmaceuticals in marine sediments 19. Analytical strategies for detecting pharmaceutical residues in marine biota 20. Occurrence of pharmaceuticals in benthic organisms 21. Occurrence and fate of pharmaceuticals in coral reef ecosystems 22. Risk assessment of pharmaceuticals and mixtures of pharmaceuticals in oceanic environments Part III: Harmful effects caused by pharmaceutical compounds to marine organisms 23. Reproductive impacts caused by pharmaceuticals on marine fish species 24. Biological effects of antidepressants on marine organisms 25. Occurrence and harmful effects of illicit drugs in marine organisms 26. Bioaccumulation, effects and trophic dilution of pharmaceutical residues in benthic and epibenthic species 27. Accumulation of pharmaceuticals in edible marine organisms: Potential risks for human health 28. Effects and pharmacokinetics of NSAIDs and other non-prescription drugs in marine organisms 29. Effective biomarkers to assess toxicity of pharmaceuticals in marine organisms 30. Lysosomal membrane stability as a sensitive biomarker of pharmaceutical toxicity in marine organisms 31. Effects of individual and mixtures of pharmaceuticals in estuarine and marine phytoplankton species 32. Effects of pharmaceuticals under climate change effects Conclusions

• ISBN: 978-0-08-102971-8
• Editorial: Elsevier
• Encuadernacion: Rústica
• Páginas: 800
• Fecha Publicación: 01/03/2021
• Nº Volúmenes: 1
• Idioma: Inglés